Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;51(2):196-209.
doi: 10.1111/1346-8138.17064. Epub 2023 Dec 12.

Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?

Teruki Dainichi  1 , Masashi Iwata  1 , Yo Kaku  1   2
Affiliations
Review

Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?

Teruki Dainichi et al. J Dermatol. 2024 Feb.

Abstract

Alopecia areata (AA) affects individuals of all ages and is intractable in severe relapsing cases. Dermatologists and other healthcare providers should consider AA in the medical context and prioritize treatment. Several randomized controlled clinical studies on Janus kinase (JAK) inhibitors with different specificities for the treatment of AA are ongoing. These studies have encouraged us to appreciate the importance of a definitive diagnosis and accurate evaluation of AA before and during treatment. Following our previous review article in 2017, here we provide the second part of this two-review series on the recent progress in the multidisciplinary approaches to AA from more than 1800 articles published between July 2016 and December 2022. This review focuses on the evaluation, diagnosis, and treatment of AA. We also provide the latest information on the safety and efficacy of JAK inhibitors for the treatment of AA and describe their mechanisms of action.

Keywords: baricitinib; deuruxolitinib (CTP-543); ifidancitinib (ATI-502); ivarmacitinib (SHR0302); ritlecitinib (PF06651600).

PubMed Disclaimer

References

REFERENCES

    1. Dainichi T, Kabashima K. Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options? J Dermatol Sci. 2017;86:3-12.
    1. Dainichi T, Iwata M, Kaku Y. Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis? J Dermatol Sci. 2023;S0923-1811:00223-2.
    1. McDonald KA, Shelley AJ, Colantonio S, Beecker J. Hair pull test: evidence-based update and revision of guidelines. J Am Acad Dermatol. 2017;76:472-477.
    1. Mahmoudi H, Salehi M, Moghadas S, Ghandi N, Teimourpour A, Daneshpazhooh M. Dermoscopic findings in 126 patients with alopecia areata: a cross-sectional study. Int J Trichology. 2018;10:118-123.
    1. Souissi A, Ben Slimane M, Alaoui F, Bacha T, Zeglaoui F, Mokni M. Flag sign: the trichoscopic feature of white hair phenomenon in alopecia areata. J Eur Acad Dermatol Venereol. 2021;35:e126-e128.

MeSH terms

Substances

LinkOut - more resources